HIV-1 Latency in Monocytes-MacrophagesReport as inadecuate

HIV-1 Latency in Monocytes-Macrophages - Download this document for free, or read online. Document in PDF available to download.

UPRES EA4266, SFR FED 4234, Pathogens and Inflammation Laboratory, Department of Virology, CHRU Besançon, University of Franche-Comte, F-25030 Besançon, France


Author to whom correspondence should be addressed.

Abstract Human immunodeficiency virus type 1 HIV-1 targets CD4+ T cells and cells of the monocyte-macrophage lineage. HIV pathogenesis is characterized by the depletion of T lymphocytes and by the presence of a population of cells in which latency has been established called the HIV-1 reservoir. Highly active antiretroviral therapy HAART has significantly improved the life of HIV-1 infected patients. However, complete eradication of HIV-1 from infected individuals is not possible without targeting latent sources of infection. HIV-1 establishes latent infection in resting CD4+ T cells and findings indicate that latency can also be established in the cells of monocyte-macrophage lineage. Monocyte-macrophage lineage includes among others, monocytes, macrophages and brain resident macrophages. These cells are relatively more resistant to apoptosis induced by HIV-1, thus are important stable hideouts of the virus. Much effort has been made in the direction of eliminating HIV-1 resting CD4+ T-cell reservoirs. However, it is impossible to achieve a cure for HIV-1 without considering these neglected latent reservoirs, the cells of monocyte-macrophage lineage. In this review we will describe our current understanding of the mechanism of latency in monocyte-macrophage lineage and how such cells can be specifically eliminated from the infected host. View Full-Text

Keywords: HIV-1; latency; monocytes; macrophages; microglial cells HIV-1; latency; monocytes; macrophages; microglial cells

Author: Amit Kumar, Wasim Abbas and Georges Herbein *



Related documents